Equities Research Analysts’ price target changes for Monday, July 13th:
AbbVie (NYSE:ABBV) had its target price boosted by BMO Capital Markets from $258.00 to $300.00. BMO Capital Markets currently has an outperform rating on the stock.
Abacus Global Management (NYSE:ABX) had its price target boosted by Piper Sandler from $10.00 to $13.00. Piper Sandler currently has a neutral rating on the stock.
Aflac (NYSE:AFL) had its price target boosted by Keefe, Bruyette & Woods from $115.00 to $120.00. They currently have a market perform rating on the stock.
AGCO (NYSE:AGCO) had its price target cut by JPMorgan Chase & Co. from $143.00 to $130.00. They currently have an overweight rating on the stock.
Agenus (NASDAQ:AGEN) had its target price boosted by HC Wainwright from $23.00 to $30.00. HC Wainwright currently has a buy rating on the stock.
Arthur J. Gallagher & Co. (NYSE:AJG) had its target price boosted by Royal Bank Of Canada from $260.00 to $300.00. The firm currently has an outperform rating on the stock.
Alkermes (NASDAQ:ALKS) had its target price increased by Needham & Company LLC from $61.00 to $62.00. They currently have a buy rating on the stock.
Allient (NASDAQ:ALNT) had its target price raised by JPMorgan Chase & Co. from $80.00 to $95.00. They currently have an overweight rating on the stock.
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its target price boosted by HC Wainwright from $470.00 to $485.00. The firm currently has a buy rating on the stock.
Allison Transmission (NYSE:ALSN) had its target price raised by JPMorgan Chase & Co. from $140.00 to $145.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Amgen (NASDAQ:AMGN) had its target price increased by Guggenheim from $340.00 to $343.00. They currently have a neutral rating on the stock.
Ameriprise Financial (NYSE:AMP) had its price target raised by Piper Sandler from $471.00 to $518.00. They currently have a neutral rating on the stock.
AON (NYSE:AON) had its target price boosted by JPMorgan Chase & Co. from $396.00 to $412.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
APA (NASDAQ:APA) had its target price cut by Raymond James Financial, Inc. from $57.00 to $50.00. Raymond James Financial, Inc. currently has an outperform rating on the stock.
Apollo Global Management (NYSE:APO) had its target price cut by Royal Bank Of Canada from $146.00 to $137.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
Apollo Global Management (NYSE:APO) had its price target lowered by Piper Sandler from $157.00 to $156.00. They currently have an overweight rating on the stock.
Apollo Global Management (NYSE:APO) had its price target reduced by BMO Capital Markets from $140.00 to $126.00. The firm currently has a market perform rating on the stock.
Ares Management (NYSE:ARES) had its target price boosted by BMO Capital Markets from $125.00 to $128.00. BMO Capital Markets currently has a market perform rating on the stock.
Axon Enterprise (NASDAQ:AXON) had its price target boosted by Piper Sandler from $674.00 to $724.00. Piper Sandler currently has an overweight rating on the stock.
AZZ (NYSE:AZZ) had its target price raised by B. Riley Financial, Inc. from $169.00 to $170.00. They currently have a buy rating on the stock.
BridgeBio Pharma (NASDAQ:BBIO) had its target price boosted by HC Wainwright from $110.00 to $120.00. They currently have a buy rating on the stock.
Badger Meter (NYSE:BMI) had its target price cut by Barclays PLC from $110.00 to $109.00. They currently have an underweight rating on the stock.
Boku (LON:BOKU) had its price target trimmed by Berenberg Bank from GBX 300 to GBX 200. They currently have a buy rating on the stock.
Bowhead Specialty (NYSE:BOW) had its target price raised by Royal Bank Of Canada from $30.00 to $38.00. The firm currently has an outperform rating on the stock.
Popular (NASDAQ:BPOP) had its price target increased by Truist Financial Corporation from $172.00 to $192.00. They currently have a buy rating on the stock.
Brown & Brown (NYSE:BRO) had its target price lowered by JPMorgan Chase & Co. from $81.00 to $78.00. They currently have a neutral rating on the stock.
Boston Scientific (NYSE:BSX) had its target price trimmed by Royal Bank Of Canada from $100.00 to $85.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Baldwin Insurance Group (NASDAQ:BWIN) had its price target increased by JPMorgan Chase & Co. from $28.00 to $30.00. The firm currently has an overweight rating on the stock.
Blackstone (NYSE:BX) had its target price cut by Royal Bank Of Canada from $173.00 to $161.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Carlyle Group (NASDAQ:CG) had its price target reduced by Royal Bank Of Canada from $58.00 to $56.00. They currently have a sector perform rating on the stock.
Check Point Software Technologies (NASDAQ:CHKP) had its price target boosted by Barclays PLC from $133.00 to $145.00. The firm currently has an equal weight rating on the stock.
Chipotle Mexican Grill (NYSE:CMG) had its price target increased by Mizuho from $40.00 to $41.00. The firm currently has an outperform rating on the stock.
Chipotle Mexican Grill (NYSE:CMG) had its target price trimmed by Citigroup Inc. from $46.00 to $45.00. Citigroup Inc. currently has a buy rating on the stock.
CNH Industrial (NYSE:CNH) had its price target boosted by JPMorgan Chase & Co. from $9.50 to $10.00. They currently have an underweight rating on the stock.
CNO Financial Group (NYSE:CNO) had its price target boosted by Keefe, Bruyette & Woods from $50.00 to $53.00. They currently have a market perform rating on the stock.
Hemab Therapeutics (NASDAQ:COAG) had its target price boosted by HC Wainwright from $40.00 to $52.00. HC Wainwright currently has a buy rating on the stock.
Capital One Financial (NYSE:COF) had its target price boosted by JPMorgan Chase & Co. from $215.00 to $245.00. They currently have an overweight rating on the stock.
Coinbase Global (NASDAQ:COIN) had its target price trimmed by BTIG Research from $280.00 to $260.00. The firm currently has a buy rating on the stock.
Corebridge Financial (NYSE:CRBG) had its price target boosted by Keefe, Bruyette & Woods from $38.00 to $40.00. They currently have an outperform rating on the stock.
Circle Internet Group (NYSE:CRCL) had its price target trimmed by Robert W. Baird from $138.00 to $100.00. The firm currently has an outperform rating on the stock.
Charles River Laboratories International (NYSE:CRL) had its target price raised by Mizuho from $192.00 to $230.00. Mizuho currently has a neutral rating on the stock.
CoStar Group (NASDAQ:CSGP) had its price target cut by Keefe, Bruyette & Woods from $50.00 to $41.00. They currently have an outperform rating on the stock.
Delta Air Lines (NYSE:DAL) had its target price boosted by JPMorgan Chase & Co. from $85.00 to $114.00. The firm currently has an overweight rating on the stock.
Dave (NASDAQ:DAVE) had its target price raised by Keefe, Bruyette & Woods from $340.00 to $485.00. The firm currently has an outperform rating on the stock.
American Axle & Manufacturing (NYSE:DCH) had its price target raised by Royal Bank Of Canada from $10.00 to $11.00. They currently have an outperform rating on the stock.
Quest Diagnostics (NYSE:DGX) had its price target raised by Robert W. Baird from $232.00 to $236.00. The firm currently has a neutral rating on the stock.
HF Sinclair (NYSE:DINO) had its price target raised by Barclays PLC from $71.00 to $81.00. They currently have an equal weight rating on the stock.
HF Sinclair (NYSE:DINO) had its target price boosted by Raymond James Financial, Inc. from $87.00 to $95.00. They currently have a strong-buy rating on the stock.
DTE Energy (NYSE:DTE) had its target price reduced by BMO Capital Markets from $154.00 to $152.00. The firm currently has a market perform rating on the stock.
Ellington Credit (NYSE:EARN) had its target price reduced by Piper Sandler from $5.25 to $5.00. Piper Sandler currently has an overweight rating on the stock.
Emerson Electric (NYSE:EMR) had its price target trimmed by KeyCorp from $185.00 to $170.00. KeyCorp currently has an overweight rating on the stock.
Eos Energy Enterprises (NASDAQ:EOSE) had its target price reduced by Stifel Nicolaus from $12.00 to $10.00. They currently have a buy rating on the stock.
Equitable (NYSE:EQH) had its target price raised by Keefe, Bruyette & Woods from $60.00 to $62.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Essent Group (NYSE:ESNT) had its price target boosted by JPMorgan Chase & Co. from $65.00 to $72.00. They currently have a neutral rating on the stock.
Edwards Lifesciences (NYSE:EW) had its target price raised by Royal Bank Of Canada from $100.00 to $110.00. The firm currently has an outperform rating on the stock.
Figure Technology Solutions (NASDAQ:FIGR) had its price target lowered by Keefe, Bruyette & Woods from $55.00 to $45.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Fortinet (NASDAQ:FTNT) had its target price raised by Barclays PLC from $155.00 to $170.00. Barclays PLC currently has an equal weight rating on the stock.
Fortrea (NASDAQ:FTRE) had its target price increased by Mizuho from $13.00 to $16.00. Mizuho currently has a neutral rating on the stock.
GCM Grosvenor (NASDAQ:GCMG) had its price target boosted by Piper Sandler from $13.00 to $15.00. They currently have an overweight rating on the stock.
Globe Life (NYSE:GL) had its price target increased by Keefe, Bruyette & Woods from $180.00 to $192.00. The firm currently has an outperform rating on the stock.
Globus Medical (NYSE:GMED) had its target price lowered by Royal Bank Of Canada from $120.00 to $115.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Genworth Financial (NYSE:GNW) had its price target increased by Keefe, Bruyette & Woods from $11.00 to $12.00. The firm currently has an outperform rating on the stock.
Group 1 Automotive (NYSE:GPI) had its target price trimmed by JPMorgan Chase & Co. from $390.00 to $380.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Goosehead Insurance (NASDAQ:GSHD) had its target price increased by JPMorgan Chase & Co. from $55.00 to $60.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Goosehead Insurance (NASDAQ:GSHD) had its target price raised by Royal Bank Of Canada from $52.00 to $55.00. They currently have a sector perform rating on the stock.
The Gym Group (LON:GYM) had its price target increased by Berenberg Bank from GBX 235 to GBX 255. Berenberg Bank currently has a buy rating on the stock.
HCA Healthcare (NYSE:HCA) had its target price reduced by Wells Fargo & Company from $436.00 to $428.00. They currently have an equal weight rating on the stock.
Huntington Ingalls Industries (NYSE:HII) had its price target cut by TD Cowen from $420.00 to $360.00. The firm currently has a buy rating on the stock.
Hinge Health (NYSE:HNGE) had its target price raised by Morgan Stanley from $72.00 to $108.00. Morgan Stanley currently has an overweight rating on the stock.
Herc (NYSE:HRI) had its target price increased by JPMorgan Chase & Co. from $140.00 to $165.00. The firm currently has a neutral rating on the stock.
Hershey (NYSE:HSY) had its price target lowered by JPMorgan Chase & Co. from $204.00 to $191.00. They currently have a neutral rating on the stock.
International General Insurance (NASDAQ:IGIC) had its price target increased by Royal Bank Of Canada from $28.00 to $30.00. They currently have an outperform rating on the stock.
Incyte (NASDAQ:INCY) had its price target increased by BMO Capital Markets from $94.00 to $112.00. BMO Capital Markets currently has a market perform rating on the stock.
Ionis Pharmaceuticals (NASDAQ:IONS) had its price target lowered by Royal Bank Of Canada from $100.00 to $85.00. The firm currently has an outperform rating on the stock.
IQVIA (NYSE:IQV) had its price target boosted by Mizuho from $215.00 to $230.00. They currently have an outperform rating on the stock.
Intuitive Surgical (NASDAQ:ISRG) had its target price reduced by Royal Bank Of Canada from $650.00 to $600.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Illinois Tool Works (NYSE:ITW) had its target price raised by JPMorgan Chase & Co. from $295.00 to $310.00. They currently have an overweight rating on the stock.
J.B. Hunt Transport Services (NASDAQ:JBHT) had its target price increased by Stifel Nicolaus from $225.00 to $261.00. They currently have a hold rating on the stock.
Johnson & Johnson (NYSE:JNJ) had its price target raised by Royal Bank Of Canada from $265.00 to $287.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Jackson Financial (NYSE:JXN) had its price target increased by Keefe, Bruyette & Woods from $125.00 to $130.00. The firm currently has a market perform rating on the stock.
KKR & Co. Inc. (NYSE:KKR) had its target price cut by Royal Bank Of Canada from $128.00 to $125.00. The firm currently has an outperform rating on the stock.
KKR & Co. Inc. (NYSE:KKR) had its price target trimmed by BMO Capital Markets from $120.00 to $112.00. They currently have an outperform rating on the stock.
Kennametal (NYSE:KMT) had its target price trimmed by JPMorgan Chase & Co. from $40.00 to $34.00. They currently have an underweight rating on the stock.
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its target price increased by Wells Fargo & Company from $57.00 to $74.00. They currently have an overweight rating on the stock.
Knight-Swift Transportation (NYSE:KNX) had its target price raised by Stifel Nicolaus from $70.00 to $85.00. They currently have a buy rating on the stock.
Leidos (NYSE:LDOS) had its price target reduced by JPMorgan Chase & Co. from $210.00 to $160.00. The firm currently has an overweight rating on the stock.
LifeStance Health Group (NASDAQ:LFST) had its target price boosted by KeyCorp from $11.00 to $13.00. The firm currently has an overweight rating on the stock.
Ethos Technologies Inc. Class A Common Stock (NASDAQ:LIFE) had its price target raised by JPMorgan Chase & Co. from $21.50 to $23.00. The firm currently has an overweight rating on the stock.
Eli Lilly and Company (NYSE:LLY) had its price target boosted by Guggenheim from $1,235.00 to $1,273.00. Guggenheim currently has a buy rating on the stock.
Lockheed Martin (NYSE:LMT) had its target price reduced by TD Cowen from $600.00 to $560.00. The firm currently has a hold rating on the stock.
Lincoln National (NYSE:LNC) had its price target raised by Keefe, Bruyette & Woods from $44.00 to $46.00. They currently have an outperform rating on the stock.
LPL Financial (NASDAQ:LPLA) had its target price raised by JPMorgan Chase & Co. from $390.00 to $408.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Landstar System (NASDAQ:LSTR) had its price target increased by Stifel Nicolaus from $175.00 to $186.00. The firm currently has a hold rating on the stock.
Mobileye Global (NASDAQ:MBLY) had its target price boosted by Royal Bank Of Canada from $9.00 to $10.00. The firm currently has a sector perform rating on the stock.
Medpace (NASDAQ:MEDP) had its target price raised by Mizuho from $495.00 to $586.00. Mizuho currently has an outperform rating on the stock.
MetLife (NYSE:MET) had its price target boosted by Keefe, Bruyette & Woods from $98.00 to $105.00. The firm currently has an outperform rating on the stock.
Magna International (NYSE:MGA) (TSE:MG) had its target price increased by Royal Bank Of Canada from $57.00 to $66.00. They currently have a sector perform rating on the stock.
Middleby (NASDAQ:MIDD) had its target price reduced by JPMorgan Chase & Co. from $185.00 to $151.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Mirion Technologies (NYSE:MIR) had its target price reduced by Morgan Stanley from $27.00 to $25.00. The firm currently has an equal weight rating on the stock.
Mercury Systems (NASDAQ:MRCY) had its target price increased by JPMorgan Chase & Co. from $99.00 to $101.00. They currently have a neutral rating on the stock.
Merck & Co., Inc. (NYSE:MRK) had its target price boosted by JPMorgan Chase & Co. from $135.00 to $140.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Merck & Co., Inc. (NYSE:MRK) had its price target boosted by BMO Capital Markets from $135.00 to $142.00. The firm currently has an outperform rating on the stock.
Merck & Co., Inc. (NYSE:MRK) had its target price raised by Guggenheim from $140.00 to $145.00. Guggenheim currently has a buy rating on the stock.
Merlin, Inc. Common Stock (NASDAQ:MRLN) had its target price reduced by TD Cowen from $11.00 to $8.00. They currently have a buy rating on the stock.
Marsh & McLennan Companies (NYSE:MRSH) had its price target boosted by JPMorgan Chase & Co. from $206.00 to $212.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
MasTec (NYSE:MTZ) had its price target increased by TD Cowen from $445.00 to $470.00. TD Cowen currently has a buy rating on the stock.
Navient (NASDAQ:NAVI) had its price target cut by JPMorgan Chase & Co. from $9.50 to $8.00. The firm currently has a neutral rating on the stock.
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by Truist Financial Corporation from $155.00 to $200.00. The firm currently has a buy rating on the stock.
Neurocrine Biosciences (NASDAQ:NBIX) had its target price raised by BMO Capital Markets from $144.00 to $170.00. They currently have a market perform rating on the stock.
NextEra Energy (NYSE:NEE) had its target price trimmed by Bank of America Corporation from $95.00 to $93.00. They currently have a neutral rating on the stock.
Netflix (NASDAQ:NFLX) had its target price trimmed by Oppenheimer Holdings, Inc. from $120.00 to $100.00. They currently have an outperform rating on the stock.
NMI (NASDAQ:NMIH) had its target price raised by JPMorgan Chase & Co. from $43.00 to $48.00. The firm currently has an overweight rating on the stock.
Neumora Therapeutics (NASDAQ:NMRA) had its price target trimmed by Royal Bank Of Canada from $7.00 to $5.00. The firm currently has an outperform rating on the stock.
Neptune Insurance (NYSE:NP) had its price target increased by JPMorgan Chase & Co. from $26.00 to $30.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Nurix Therapeutics (NASDAQ:NRIX) had its price target raised by Mizuho from $30.00 to $34.00. The firm currently has an outperform rating on the stock.
NXP Semiconductors (NASDAQ:NXPI) had its price target boosted by Bank of America Corporation from $275.00 to $310.00. They currently have a neutral rating on the stock.
OKYO Pharma (NASDAQ:OKYO) had its target price lowered by HC Wainwright from $7.00 to $5.00. The firm currently has a buy rating on the stock.
Oxford Nanopore Technologies (LON:ONT) had its price target trimmed by Berenberg Bank from GBX 230 to GBX 220. They currently have a buy rating on the stock.
Montrose Environmental Group (NYSE:ONT) had its target price trimmed by JPMorgan Chase & Co. from $24.00 to $22.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Blue Owl Capital (NYSE:OWL) had its target price lowered by BMO Capital Markets from $12.00 to $11.00. They currently have an outperform rating on the stock.
PACCAR (NASDAQ:PCAR) had its price target boosted by JPMorgan Chase & Co. from $140.00 to $155.00. The firm currently has an overweight rating on the stock.
Procore Technologies (NYSE:PCOR) had its target price cut by Barclays PLC from $65.00 to $50.00. Barclays PLC currently has an overweight rating on the stock.
Pfizer (NYSE:PFE) had its target price reduced by Guggenheim from $36.00 to $35.00. Guggenheim currently has a buy rating on the stock.
Pfizer (NYSE:PFE) had its price target trimmed by BMO Capital Markets from $34.00 to $30.00. The firm currently has an outperform rating on the stock.
Principal Financial Group (NASDAQ:PFG) had its target price raised by Keefe, Bruyette & Woods from $102.00 to $112.00. They currently have a market perform rating on the stock.
The Pennant Group (NASDAQ:PNTG) had its target price boosted by Wells Fargo & Company from $41.00 to $45.00. The firm currently has an overweight rating on the stock.
Insulet (NASDAQ:PODD) had its price target trimmed by Royal Bank Of Canada from $280.00 to $245.00. They currently have an outperform rating on the stock.
Permian Resources (NYSE:PR) had its price target reduced by Truist Financial Corporation from $25.00 to $22.00. Truist Financial Corporation currently has a buy rating on the stock.
Primerica (NYSE:PRI) had its target price boosted by Keefe, Bruyette & Woods from $305.00 to $323.00. The firm currently has a market perform rating on the stock.
Prudential Financial (NYSE:PRU) had its target price increased by Keefe, Bruyette & Woods from $106.00 to $113.00. The firm currently has a market perform rating on the stock.
Pershing Square (NYSE:PS) had its price target cut by Royal Bank Of Canada from $40.00 to $38.00. They currently have a sector perform rating on the stock.
PTC (NASDAQ:PTC) had its price target trimmed by Barclays PLC from $185.00 to $150.00. The firm currently has an overweight rating on the stock.
QXO (NYSE:QXO) had its target price reduced by Citigroup Inc. from $28.00 to $25.00. Citigroup Inc. currently has a buy rating on the stock.
Resideo Technologies (NYSE:REZI) had its target price lowered by Morgan Stanley from $50.00 to $45.00. Morgan Stanley currently has an overweight rating on the stock.
Rocket Companies (NYSE:RKT) had its target price reduced by JPMorgan Chase & Co. from $16.00 to $15.50. The firm currently has a neutral rating on the stock.
Riskified (NYSE:RSKD) had its price target raised by Keefe, Bruyette & Woods from $5.25 to $5.50. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
RXO (NYSE:RXO) had its target price increased by Stifel Nicolaus from $22.00 to $30.00. They currently have a buy rating on the stock.
Ryan Specialty (NYSE:RYAN) had its target price increased by JPMorgan Chase & Co. from $37.00 to $39.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.
Sonic Automotive (NYSE:SAH) had its target price trimmed by JPMorgan Chase & Co. from $77.00 to $76.00. The firm currently has an underweight rating on the stock.
Saia (NASDAQ:SAIA) had its price target lowered by Raymond James Financial, Inc. from $477.00 to $475.00. Raymond James Financial, Inc. currently has an outperform rating on the stock.
SEI Investments (NASDAQ:SEIC) had its target price boosted by Piper Sandler from $105.00 to $114.00. Piper Sandler currently has an overweight rating on the stock.
Selective Insurance Group (NASDAQ:SIGI) had its target price increased by Royal Bank Of Canada from $100.00 to $110.00. Royal Bank Of Canada currently has an outperform rating on the stock.
SLM (NASDAQ:SLM) had its price target increased by JPMorgan Chase & Co. from $24.00 to $25.00. The firm currently has an underweight rating on the stock.
SmartRent (NYSE:SMRT) had its target price reduced by Keefe, Bruyette & Woods from $1.40 to $1.20. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
StepStone Group (NASDAQ:STEP) had its price target reduced by BMO Capital Markets from $62.00 to $50.00. They currently have an outperform rating on the stock.
Stellantis (NYSE:STLA) had its price target trimmed by TD Cowen from $9.00 to $6.00. They currently have a hold rating on the stock.
Seagate Technology (NASDAQ:STX) had its price target boosted by Citigroup Inc. from $1,150.00 to $1,240.00. Citigroup Inc. currently has a buy rating on the stock.
Synchrony Financial (NYSE:SYF) had its target price trimmed by JPMorgan Chase & Co. from $81.00 to $78.00. They currently have a neutral rating on the stock.
Synchrony Financial (NYSE:SYF) had its target price increased by HSBC Holdings plc from $93.00 to $97.00. They currently have a buy rating on the stock.
Spyre Therapeutics (NASDAQ:SYRE) had its target price raised by Mizuho from $84.00 to $120.00. They currently have an outperform rating on the stock.
Tenable (NASDAQ:TENB) had its price target boosted by Barclays PLC from $28.00 to $41.00. They currently have an equal weight rating on the stock.
Terex (NYSE:TEX) had its price target raised by JPMorgan Chase & Co. from $69.00 to $80.00. The firm currently has a neutral rating on the stock.
TG Therapeutics (NASDAQ:TGTX) had its target price boosted by HC Wainwright from $70.00 to $77.00. They currently have a buy rating on the stock.
The Hanover Insurance Group (NYSE:THG) had its price target increased by Royal Bank Of Canada from $195.00 to $215.00. They currently have a sector perform rating on the stock.
Timken (NYSE:TKR) had its target price raised by JPMorgan Chase & Co. from $150.00 to $160.00. The firm currently has an overweight rating on the stock.
TPG (NASDAQ:TPG) had its price target lowered by BMO Capital Markets from $52.00 to $50.00. BMO Capital Markets currently has an outperform rating on the stock.
TriplePoint Venture Growth BDC (NYSE:TPVG) had its target price lowered by Piper Sandler from $5.50 to $5.00. Piper Sandler currently has a neutral rating on the stock.
LendingTree (NASDAQ:TREE) had its price target cut by Keefe, Bruyette & Woods from $70.00 to $58.00. The firm currently has an outperform rating on the stock.
Trimble (NASDAQ:TRMB) had its price target cut by JPMorgan Chase & Co. from $88.00 to $75.00. The firm currently has an overweight rating on the stock.
TWFG (NASDAQ:TWFG) had its target price boosted by JPMorgan Chase & Co. from $24.00 to $27.00. They currently have a neutral rating on the stock.
TWFG (NASDAQ:TWFG) had its price target boosted by Royal Bank Of Canada from $27.00 to $30.00. The firm currently has an outperform rating on the stock.
Textron (NYSE:TXT) had its price target cut by TD Cowen from $115.00 to $105.00. TD Cowen currently has a hold rating on the stock.
Universal Health Services (NYSE:UHS) had its target price raised by Wells Fargo & Company from $165.00 to $166.00. The firm currently has an equal weight rating on the stock.
UnitedHealth Group (NYSE:UNH) had its price target raised by Wells Fargo & Company from $397.00 to $485.00. Wells Fargo & Company currently has an overweight rating on the stock.
Union Pacific (NYSE:UNP) had its price target boosted by Raymond James Financial, Inc. from $310.00 to $363.00. The firm currently has a strong-buy rating on the stock.
United Rentals (NYSE:URI) had its target price increased by JPMorgan Chase & Co. from $1,050.00 to $1,100.00. The firm currently has an overweight rating on the stock.
Valero Energy (NYSE:VLO) had its target price increased by Raymond James Financial, Inc. from $300.00 to $340.00. They currently have a strong-buy rating on the stock.
Voya Financial (NYSE:VOYA) had its price target boosted by Keefe, Bruyette & Woods from $92.00 to $109.00. They currently have an outperform rating on the stock.
Varonis Systems (NASDAQ:VRNS) had its price target boosted by Barclays PLC from $33.00 to $52.00. The firm currently has an overweight rating on the stock.
Wabtec (NYSE:WAB) had its price target increased by JPMorgan Chase & Co. from $290.00 to $300.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Waste Connections (NYSE:WCN) had its price target reduced by JPMorgan Chase & Co. from $210.00 to $195.00. They currently have an overweight rating on the stock.
Werner Enterprises (NASDAQ:WERN) had its price target raised by Stifel Nicolaus from $36.00 to $40.00. Stifel Nicolaus currently has a hold rating on the stock.
Wealthfront (NASDAQ:WLTH) had its target price reduced by Keefe, Bruyette & Woods from $11.00 to $10.50. They currently have a market perform rating on the stock.
Western Union (NYSE:WU) had its price target reduced by JPMorgan Chase & Co. from $9.00 to $8.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.
Global Medical REIT (NYSE:XRN) had its target price increased by BMO Capital Markets from $39.00 to $40.00. They currently have a market perform rating on the stock.
Zillow Group (NASDAQ:Z) had its price target cut by Keefe, Bruyette & Woods from $50.00 to $37.00. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
Receive News & Ratings for AbbVie Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbbVie Inc and related companies with MarketBeat.com's FREE daily email newsletter.
